XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Research and development $ 3,955 $ 17,676 $ 22,737 $ 49,107
General and administrative 7,905 12,947 59,101 62,852
Total operating expenses 11,860 30,623 81,838 111,959
Operating loss (11,860) (30,623) (81,838) (111,959)
Interest income 1,167 2,618 3,646 6,710
Other income (loss), net (114) 62 (242) 321
Gain from change in fair value of warrant liabilities 0 0 0 108,183
Net income (loss) $ (10,807) $ (27,943) $ (78,434) $ 3,255
Shares used in computing net income (loss) per share, basic (in shares) 48,308 47,976 48,293 45,734
Net income (loss) per share, basic (in dollars per share) $ (0.22) $ (0.58) $ (1.62) $ 0.07
Adjustment for change in fair value of warrant liabilities $ 0 $ 0 $ 0 $ (43,793)
Adjusted numerator, diluted $ (10,807) $ (27,943) $ (78,434) $ (40,538)
Shares used in computing net loss per share, diluted (in shares) 48,308 47,976 48,293 46,101
Net loss per share, diluted (in dollars per share) $ (0.22) $ (0.58) $ (1.62) $ (0.88)